Eric A Finkelstein
Overview
Explore the profile of Eric A Finkelstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
199
Citations
7127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Complementary and Alternative Medicine Use in the Last Year of Life: The COMPASS Cancer Cohort Study
Teo I, Chow M, Chaudhry I, Malhotra C, Ozdemir S, Finkelstein E
J Pain Symptom Manage
. 2025 Jan;
69(4):e257-e264.
PMID: 39755285
Context: There has been growing interest in the role of complementary and alternative medicine (CAM) as part of end-of-life care. Objectives: This study prospectively examined the prevalence, predictors and outcomes...
2.
Herring S, Yu D, Darden N, Bailer B, Cruice J, Albert J, et al.
Obesity (Silver Spring)
. 2024 Jul;
32(9):1646-1657.
PMID: 39041425
Objective: The objective of this study was to evaluate the efficacy of a mobile health (mHealth)-delivered behavioral intervention on changes in postpartum weight and cardiometabolic risk factors (blood pressure [BP],...
3.
Chay J, Su R, Kamano J, Andama B, Bloomfield G, Delong A, et al.
Lancet Glob Health
. 2024 Jul;
12(8):e1331-e1342.
PMID: 39030063
Background: The Bridging Income Generation with Group Integrated Care (BIGPIC) trial in rural Kenya showed that integrating usual care with group medical visits or microfinance interventions reduced systolic blood pressure...
4.
Chay J, Koh W, Tan K, Finkelstein E
Ann Acad Med Singap
. 2024 Jun;
53(4):233-240.
PMID: 38920180
Background: Cognitive impairment (CI) raises risks for unplanned healthcare utilisation and expenditures and for premature mortality. It may also reduce risks for planned expenditures. Therefore, the net cost implications for...
5.
Baid D, Lakdawalla D, Finkelstein E
Value Health Reg Issues
. 2024 Jun;
43:101003.
PMID: 38838425
Objectives: Cost-effectiveness analyses are increasingly used to inform subvention decisions for moderately life extending treatments but apply several simplifying assumptions that may be inconsistent with public preferences. Contrary to standard...
6.
Mallinson P, Lieber J, Kinra S, Debbarma A, Walls H, Bhogadi S, et al.
Lancet Reg Health Southeast Asia
. 2024 May;
24:100399.
PMID: 38756154
No abstract available.
7.
Elias H, Ozdemir S, Bairavi J, Achieng E, Finkelstein E
Afr J Prim Health Care Fam Med
. 2024 May;
16(1):e1-e6.
PMID: 38708729
Background: Cancer is the third leading cause of death in Kenya. Yet, little is known about prognostic awareness and preferences for prognostic information. Aim: To assess the prevalence of prognostic...
8.
Chay J, Jafar T, Su R, Shirore R, Tan N, Finkelstein E
J Am Heart Assoc
. 2024 Apr;
13(8):e033631.
PMID: 38606776
Background: The SingHypertension primary care clinic intervention, which consisted of clinician training in hypertension management, subsidized single-pill combination medications, nurse-delivered motivational conversations and telephone follow-ups, improved blood pressure control and...
9.
Chay J, Choo J, Finkelstein E
Nephrology (Carlton)
. 2024 Mar;
29(5):278-287.
PMID: 38443742
Introduction: Hyperkalaemia (HK) is prevalent among patients with chronic kidney disease (CKD) and chronic heart failure, especially if they are treated with renin-angiotensin-aldosterone system inhibitors (RAASi). This study evaluated the...
10.
Manalo M, Yang G, Reandelar Jr M, Ozdemir Van Dyk S, Malhotra C, Finkelstein E
BMJ Support Palliat Care
. 2023 Dec;
PMID: 38050040
Objective: In Asian cultures, the belief that full disclosure would harm the patient's health would lead to non-disclosure. The study aimed to determine whether making patients aware of the extent...